{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:32:57Z","timestamp":1794573177476,"version":"4.9.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11606-023-08307-z","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T21:01:51Z","timestamp":1689195711000},"page":"3242-3246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Changing Medical Publishing Industry: Economics, Expansion, and Equity"],"prefix":"10.1007","volume":"38","author":[{"given":"Christopher M.","family":"Booth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2772-3121","authenticated-orcid":false,"given":"Allan S.","family":"Detsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"8307_CR1","unstructured":"Buranyi. Is the staggeringly profitable business of scientific publishing bad for science? The Guradian 2017. Available at: https:\/\/www.theguardian.com\/science\/2017\/jun\/27\/profitable-business-scientific-publishing-bad-for-science. Last accessed March 30, 2023."},{"issue":"1","key":"8307_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jama.2018.19320","volume":"321","author":"LM Shwartz","year":"2019","unstructured":"Shwartz LM and Woloshin S. Medical Marketing in the United States, 1997-2016. JAMA 2019; 321(1): 80-96.","journal-title":"JAMA"},{"key":"8307_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMms1900864","volume":"380","author":"CJ Haug","year":"2019","unstructured":"Haug CJ. No Free Lunch - What Price Plan S for Scientific Publishing? New Engl J Med 2019; 380: 1181-1185.","journal-title":"New Engl J Med"},{"key":"8307_CR4","unstructured":"Directory of Open Access Journals. Available at: https:\/\/doaj.org\/search\/journals?source=%7B%22query%22%3A%7B%22match_all%22%3A%7B%7D%7D%2C%22size%22%3A50%2C%22sort%22%3A%5B%7B%22created_date%22%3A%7B%22order%22%3A%22desc%22%7D%7D%5D%2C%22track_total_hits%22%3Atrue%7D. Last accessed March 30, 2023."},{"key":"8307_CR5","unstructured":"McKenzie L. Big deal for open access. Inside Higher Ed. 2021. Available at: https:\/\/www.insidehighered.com\/news\/2021\/03\/17\/university-california-reaches-new-open-access-agreement-elsevier. Last accessed March 30, 2023."},{"key":"8307_CR6","doi-asserted-by":"publisher","unstructured":"Butler LA, Matthias L, Simard MA, Mongeon P, Haustein S. The Oligopoly's Shift to Open Access. How For-Profit Publishers Benefit from Article Processing Charges (Version v1). 2022; Zenodo. https:\/\/doi.org\/10.5281\/zenodo.7057144. Available at: https:\/\/zenodo.org\/record\/7057144#.YyVojOxBy3I. Last accessed March 30, 2023.","DOI":"10.5281\/zenodo.7057144"},{"key":"8307_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/489179a","volume":"489","author":"J Beall","year":"2012","unstructured":"Beall J. Predatory publishers are corrupting open access. Nature 2012; 489:179-179.","journal-title":"Nature"},{"key":"8307_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1056\/NEJMp1214750","volume":"368","author":"C Haug","year":"2013","unstructured":"Haug C. The Downside of Open-Access Publishing. New Engl J Med 2013; 368: 791-793.","journal-title":"New Engl J Med"},{"key":"8307_CR9","doi-asserted-by":"crossref","unstructured":"Bibbins-Domingo K, Shields B, Ayanian JZ, et al. Public Access to Scientific Research Findings and Principles of Biomedical Research\u2014A New Policy for the JAMA Network. JAMA 2022 e-published online December 14, 2022.","DOI":"10.1001\/jamanetworkopen.2022.52325"},{"key":"8307_CR10","doi-asserted-by":"publisher","first-page":"e047107","DOI":"10.1136\/bmjopen-2020-047107","volume":"11","author":"MK Ellingson","year":"2021","unstructured":"Ellingson MK, Shi X, Skydell JJ, et al. Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year. BMJ Open 2021;11:e047107. doi: https:\/\/doi.org\/10.1136\/bmjopen-2020-047107.","journal-title":"BMJ Open"},{"key":"8307_CR11","doi-asserted-by":"crossref","unstructured":"Ioannidis JPA, Pezzullo AM, Boccia S. The Rapid Growth of Mega-Journals: Threats and Opportunities. JAMA; 2023; ePub online March 20, 2023","DOI":"10.1001\/jama.2023.3212"},{"key":"8307_CR12","doi-asserted-by":"crossref","unstructured":"Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLOS Medicine; 2010: 21;7(9):e1000326.","DOI":"10.1371\/journal.pmed.1000326"},{"key":"8307_CR13","doi-asserted-by":"crossref","unstructured":"Aczel, B., Szaszi, B. & Holcombe, A.O. A billion-dollar donation: estimating the cost of researchers\u2019 time spent on peer review. Res Integr Peer Rev 2021; 6 (14).","DOI":"10.1186\/s41073-021-00118-2"},{"issue":"6","key":"8307_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/CIRCOUTCOMES.115.002415","volume":"8","author":"HM Krumholz","year":"2015","unstructured":"Krumholz HM. The end of journals. Circ Cardiovasc Qual Outcomes 2015; 8(6): 533-534.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"18","key":"8307_CR15","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2020.17529","volume":"324","author":"HM Krumholz","year":"2020","unstructured":"Krumholz HM Bloom T, Sever R, et al. Submissions and downloads of preprints in the first year of medRxiv. JAMA 2020; 324(18): 1903-1905.","journal-title":"JAMA"},{"key":"8307_CR16","doi-asserted-by":"publisher","unstructured":"Sever R, Roeder T, Hindle S, et al. bioRxiv: the preprint server for biology. bioRxiv. doi: https:\/\/doi.org\/10.1101\/833400. Available at: bioRxiv: the preprint server for biology | bioRxiv. Last accessed March 30, 2023.","DOI":"10.1101\/833400"},{"key":"8307_CR17","unstructured":"Heather J. Preprints aren\u2019t the problem \u2013 WE are the problem. Medium. Available at: https:\/\/jamesheathers.medium.com\/preprints-arent-the-problem-we-are-the-problem-75d29a317625. Last accessed March 30, 2023."},{"key":"8307_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jclinepi.2016.02.012","volume":"73","author":"JPA Ioaniddis","year":"2016","unstructured":"Ioaniddis JPA. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epi 2016; 73: 82-86.","journal-title":"J Clin Epi"},{"issue":"4","key":"8307_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/014107680609900414","volume":"99","author":"R Smith","year":"2006","unstructured":"Smith R. Peer review: a flawed process at the heart of science and journals. J R Soc Med 2006; 99(4): 178\u2013182.","journal-title":"J R Soc Med"},{"issue":"21","key":"8307_CR20","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1001\/jama.287.21.2784","volume":"287","author":"T Jefferson","year":"2002","unstructured":"Jefferson T, Alderson P, Wager E, Davidoff F. Effects of Editorial Peer Review: A Systematic Review. JAMA 2002; 287(21):2784-2786.","journal-title":"JAMA"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08307-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-023-08307-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08307-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T23:03:58Z","timestamp":1720739038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-023-08307-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":20,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["8307"],"URL":"https:\/\/doi.org\/10.1007\/s11606-023-08307-z","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"7 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Drs. Booth and Detsky have no conflicts to declare.Dr. Ross currently receives research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST), from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164, R01HL144644), and from Arnold Ventures; in addition, Dr. Ross is an expert witness at the request of Relator\u2019s attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen Inc., was until recently the U.S. Outreach and Research Editor at BMJ, is a Deputy Editor at JAMA, and is a co-founder of medRxiv.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}